Loss to follow-up and mortality among pregnant women referred to a community clinic for antiretroviral treatment
about
WHO 2010 guidelines for prevention of mother-to-child HIV transmission in Zimbabwe: modeling clinical outcomes in infants and mothersWhat will it take to eliminate pediatric HIV? Reaching WHO target rates of mother-to-child HIV transmission in Zimbabwe: a model-based analysisAddressing the Achilles' heel in the HIV care continuum for the success of a test-and-treat strategy to achieve an AIDS-free generation.Patient retention in antiretroviral therapy programs up to three years on treatment in sub-Saharan Africa, 2007-2009: systematic review.Correcting for mortality among patients lost to follow up on antiretroviral therapy in South Africa: a cohort analysis.Factors influencing retention in care after starting antiretroviral therapy in a rural South African programme.Family-centred approaches to the prevention of mother to child transmission of HIV.Retention in HIV care between testing and treatment in sub-Saharan Africa: a systematic review.Feasibility of early infant diagnosis of HIV in resource-limited settings: the ANRS 12140-PEDIACAM study in Cameroon.HIV-infected women on antiretroviral treatment have increased mortality during pregnant and postpartum periodsPrevalent pregnancy, biological sex, and virologic response to antiretroviral therapyFollow-up care among HIV-infected pregnant women in MississippiDisengagement of HIV-positive pregnant and postpartum women from antiretroviral therapy services: a cohort study.Determinants and consequences of failure of linkage to antiretroviral therapy at primary care level in Blantyre, Malawi: a prospective cohort study.Retention in care among HIV-infected patients in resource-limited settings: emerging insights and new directions.Incident pregnancy and time to death or AIDS among HIV-positive women receiving antiretroviral therapyStrategies to improve patient retention on antiretroviral therapy in sub-Saharan Africa.Virological breakthrough: a risk factor for loss to followup in a large community-based cohort on antiretroviral therapy.Linking women who test HIV-positive in pregnancy-related services to HIV care and treatment services in Kenya: a mixed methods prospective cohort study.One-year outcomes of women started on antiretroviral therapy during pregnancy before and after the implementation of Option B+ in Malawi: A retrospective chart review.Different factors associated with loss to follow-up of infants born to HIV-infected or uninfected mothers: observations from the ANRS 12140-PEDIACAM study in Cameroon.Virologic and immunologic failure, drug resistance and mortality during the first 24 months postpartum among HIV-infected women initiated on antiretroviral therapy for life in the Mitra plus Study, Dar es Salaam, TanzaniaA mixed-methods approach to understanding barriers to postpartum retention in care among low-income, HIV-infected women.Risk factors for loss to follow-up prior to ART initiation among patients enrolling in HIV care with CD4+ cell count ≥200 cells/μL in the multi-country MTCT-Plus Initiative.Introduction and evaluation of a 'pre-ART care' service in Swaziland: an operational research studyThe Link4Health study to evaluate the effectiveness of a combination intervention strategy for linkage to and retention in HIV care in Swaziland: protocol for a cluster randomized trialFacility-Level Factors Influencing Retention of Patients in HIV Care in East Africa.Empowering patients to link to care and treatment: qualitative findings about the role of a home-based HIV counselling, testing and linkage intervention in South Africa.Quantifying and addressing losses along the continuum of care for people living with HIV infection in sub-Saharan Africa: a systematic review.Treatment Failure, Drug Resistance, and CD4 T-Cell Count Decline Among Postpartum Women on Antiretroviral Therapy in South AfricaFrequency and factors associated with adherence to and completion of combination antiretroviral therapy for prevention of mother to child transmission in western KenyaCost-effectiveness of World Health Organization 2010 guidelines for prevention of mother-to-child HIV transmission in ZimbabweLoss to follow-up before and after delivery among women testing HIV positive during pregnancy in Johannesburg, South AfricaRetention in Care of HIV-Positive Postpartum Females in Kumasi, GhanaThe impact of revised PMTCT guidelines: a view from a public sector ARV clinic in Cape Town, South Africa.Oral antiretroviral drugs as public health tools for HIV prevention: global implications for adherence, drug resistance, and the success of HIV treatment programs.Evolving uses of oral reverse transcriptase inhibitors in the HIV-1 epidemic: from treatment to preventionAttrition from HIV testing to antiretroviral therapy initiation among patients newly diagnosed with HIV in Haiti.Retention in Care among HIV-Infected Pregnant Women in Haiti with PMTCT Option B.Loss to follow-up in a community clinic in South Africa--roles of gender, pregnancy and CD4 count.
P2860
Q28478406-BB8C7E8D-AF8D-484F-A912-8CC70E8F4D6FQ28478769-97144235-2A44-4311-BD6A-1E74F4672B11Q30363571-671D571A-86BF-4017-9653-2F07C45FC431Q33619740-7A13F3CF-531F-4023-B3D2-EF2F1DE7421EQ33838306-C82FD0B7-0128-4FA4-8709-B0094076B257Q33894714-FE80DC05-B7E0-463D-8DAC-796490DFAC78Q33935673-8B0F1788-EA80-475D-A5C0-1F5EA8CE1B23Q33979497-07B14F05-13ED-43FB-AE22-FDC00D4BC812Q33982980-27492D6E-5734-4E57-A951-9900F27686E3Q34081657-536B1879-1153-4DE5-8423-C0D4CAFFAE26Q34226031-F17391B1-2ACB-41BE-8AFC-CB304135D195Q34249225-729D8DB6-2FCA-4800-A137-9AB01F5B36BDQ34318914-0868440C-C3C7-4784-9197-DC3C77D85795Q34416119-AFE999A2-7800-4C70-B80E-AF14D7091775Q34495138-59EA7A84-3B77-4A0A-8396-C27DA0CDBB4FQ34631738-D2FFC62C-8D20-4E92-AC35-15AB10B71835Q34687565-71840661-610F-44E5-BB62-AED88D35445CQ35058006-43828CF5-8D72-4EB1-9DC2-8BCBFAEB515CQ35124829-F8509251-1C94-47CD-AF1A-3EFC8A058D18Q35169574-9BA9ACA9-62D9-4C0A-86E6-62C5F104656FQ35174331-7C08A30E-EC6C-400D-BAA4-A96B455F687DQ35357751-2EAD9A61-DEE9-41B8-BD73-07222274C03EQ35641737-9B7BC8CE-F9FA-4596-9936-E900D7E74BC1Q35673424-CC55165E-7CB7-400D-B225-B52349FABE66Q35838211-63A44571-5941-4A84-957B-AF800F54D79DQ35864187-83EA6884-FA11-4C07-B562-FEBFC9DD76B6Q36100413-D7ECFCFB-217B-4B96-88B2-5A5FBB9C81B4Q36132607-1C12B040-BB4F-41A0-8DE1-562C1AF796D2Q36414972-CC63393D-86A7-4E8D-8D21-874C9070472CQ36463979-45322C15-26DD-4B38-8453-FF8B28E3DD44Q36508292-31465288-0DE9-412D-A725-E467A814A549Q36517778-6CCEE390-6A3E-4260-ACE2-964B89CEB04BQ36691692-FE7776ED-8555-47B3-BA0E-58A6ACEF5FC8Q36739663-87338098-0EE5-4381-9F5B-EB611891AF27Q37000336-586F48E7-FBC3-4894-AD23-653F229DC46DQ37003938-E4BE26C0-B142-425A-9E41-61D93E3AE333Q37071435-9209B0C7-7DBE-4222-99F3-255A1DAE2380Q37086356-4A18E323-C40B-481B-A2DC-4F3B8802990DQ37249851-30924859-6F89-44FB-BCE0-CE83DED8C5A6Q37326887-C2623D59-69E3-4210-8652-127450F63BEA
P2860
Loss to follow-up and mortality among pregnant women referred to a community clinic for antiretroviral treatment
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Loss to follow-up and mortalit ...... c for antiretroviral treatment
@en
Loss to follow-up and mortalit ...... for antiretroviral treatment.
@nl
type
label
Loss to follow-up and mortalit ...... c for antiretroviral treatment
@en
Loss to follow-up and mortalit ...... for antiretroviral treatment.
@nl
prefLabel
Loss to follow-up and mortalit ...... c for antiretroviral treatment
@en
Loss to follow-up and mortalit ...... for antiretroviral treatment.
@nl
P2860
P50
P1433
P1476
Loss to follow-up and mortalit ...... c for antiretroviral treatment
@en
P2093
Eugene Zwane
P2860
P304
P356
10.1097/QAD.0B013E32830EBCEE
P407
P577
2008-08-01T00:00:00Z